The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
prosus india portfolio shows mixed returns with pharmeasy lagging behind
PharmEasy continues to negatively impact Prosus’ India portfolio with an internal rate of return (IRR) of -38% in H1FY25, an improvement from -44% the previous year. In contrast, ElasticRun led with a 23% IRR, while Swiggy, PayU, and Meesho each reported 20-21%. Eruditus, despite a lower IRR of 14%, remains the only positive performer in the edtech sector for Prosus.